N. H. Bjarnason

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

Steven R. Cummings, Stephen Eckert, D Grady et al. · JAMA · 1999 · 1.9K citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women

Pernille Ravn, Giovanni Cizza, N. H. Bjarnason et al. · Journal of Bone and Mineral Research · 1999 · 455 citations

Medicine, Endocrinology, Bone Metabolism +16

Mechanism of circadian variation in bone resorption

N. H. Bjarnason, Eva EG Henriksen, Peter Alexandersen et al. · Bone · 2002 · 261 citations

Medicine, Endocrinology, Physiology +14

Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis

N. H. Bjarnason, Somnath Sarkar, T.A. Duong et al. · Osteoporosis International · 2001 · 235 citations

Medicine, Endocrinology, Orthopedic Surgery +17

Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies

Christian Rosenquist, Per Qvist, N. H. Bjarnason et al. · Clinical Chemistry · 1995 · 179 citations

Pharmacy, Endocrinology, Antibody Engineering +5